Catecholamine-induced adipocyte lipolysis in human hyperthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 1, 1997, Pages 159-166

  Hellström, Lena ^a   Wahrenberg, Hans ^a   Reynisdottir, Signy ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BUCLADESINE; CATECHOLAMINE; CLONIDINE; CYCLIC AMP; DOBUTAMINE; FORSKOLIN; NORADRENALIN; TERBUTALINE; THYROID HORMONE; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; LIGAND BINDING; LIPID METABOLISM; LIPOLYSIS; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY; THYROTOXICOSIS;

ADIPOCYTES; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADULT; BUCLADESINE; CLONIDINE; DOBUTAMINE; FEMALE; FORSKOLIN; HUMANS; HYPERTHYROIDISM; LIPOLYSIS; MALE; MIDDLE AGED; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA; TERBUTALINE;

EID: 0031024934     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.1.159     Document Type: Article

References (33)

1. Bilezikian JP, Loeb JN. 1983 The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 4:378-388.
2. Wahrenberg H, Wennlund A, Arner P. 1994 Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients. J Clin Endocrinol Metab. 78:898-903.
3. Engfeldt P, Arner P, Bolinder J, Wennlund A, Östman J. 1982 Phosphodiesterase activity in human subcutaneous adipose tissue in hyper- and hypothyroidism. J Clin Endocrinol Metab. 54:625-629.
4. 3-adrenoceptor in man. Br J Pharmacol. 110:929-936.
5. Lafontan, M, Berlan M. 1993 Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res. 34:1057-1091.
6. Ros M, Northup JK, Malbon CC. 1988 Steady-state levels of G-proteins and β-adrenergic receptors in rat fat cells. J Biol Chem. 263:4352-4368.
7. Malbon CC, Moreno FJ, Cabelli RJ, Fain JN. 1978 Fat cell adenylate cyclase and β-adrenergic receptors in altered thyroid states. J Biol Chem. 253:671-678.
8. Hammond HK, White FC, Buxton ILO, Saltzstein P, Brunton LL, Longhurst JC. 1987 Increased myocardial β-receptors and adrenergic responses in hyperthyroid pigs. Am J Physiol. 252:H283-H290.
9. 1- and β2-adrenergic receptors and cyclic adenosine 3′,5′-monophosphate generation. Endocrinology. 136:3267-3276.
10. 1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem. 266:15863-15869.
11. 3-adrenergic receptors in brown and white adipose tissue. Endocrinology. 136:3277-3284.
12. Rapiejko PJ, Malbon CC. 1987 Short-term hyperthyroidism modulates adenosine receptors and catalytic activity of adenylate cyclase in adipocytes. Biochem J. 241:765-771.
13. Rapiejko PJ, Watkins DC, Ros M, Malbon CC. 1989 Thyroid hormones regulate G-protein β-subunit mRNA expression in vivo. J Biol Chem. 264:16183-16189.
14. Kolaczynski JW, Morales LM, Moore JH, et al. 1994 A new technique for biopsy of human abdominal fat under local anaesthesia with lidocaine. Int J Obes. 18:161-166.
15. Rodbell M. 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 239:375-380.
16. 2-adrenoceptors. Diabetologia. 37:428-435.
17. 2-adrenoceptor expression in fat cells. J Clin Invest. 90:2175-2186.
18. Hellmér J, Arner P, Lundin A. 1989 Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem. 177:132-137.
19. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P. 1994 Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest. 93:2590-2599.
20. Östman J, Arner P, Kimura H, Wahrenberg H, Engfeldt P. 1984 Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes. Eur J Clin Invest. 13:383-391.
21. Reynisdottir S, Eriksson M, Angelin B, Arner P. 1995 Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J Clin Invest. 95:2161-2169.
22. Scatchard G. 1948 The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 51:660-672.
23. Munson PJ, Rodbard D. 1980 LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal Biochem. 107:220-239.
24. Fredriksson G, Strålfors P, Nilsson NÖ, Beifrage P. 1981 Hormone-sensitive lipase from rat. Methods Enzymol. 71:636-646.
25. Frayn KN, Langin D, Holm C, Belfrage P. 1993 Hormone-sensitive lipase: quantitation of enzyme activity and mRNA in small biopsies of human adipose tissue. Clin Chim Acta. 216:183-189.
26. Arner P, Hellmér J, Wennlund A, Östman J, Engfeldt P. 1988 Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate. Eur J Pharmacol. 146:45-56.
27. Kenakin T. 1984 The classification of drugs and drug receptors in isolated tissue. Pharmacol Rev. 36:165-214.
28. Elks ML, Manganiello VC. 1985 Effects of thyroid hormone on regulation of lipolysis and adenosine 3′,5′-monophosphate metabolism in 3T3-L1 adipocytes. Endocrinology. 117:947-953.
29. 2- and β-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism. 36:1031-1039.
30. Wahrenberg H, Engfeldt P, Arner P, Wennlund A, Östman J. 1986 Adrenergic regulation of lipolysis in human adipocytes: findings in hyper- and hypothyroidism. J Clin Endocrinol Metab. 63:631-638.
31. Hellmér J, Wahrenberg H, Arner P. 1992 Stability over time of adrenergic sensitivity in isolated fat cells. Int J Obes. 16:23-28.
32. Del Rio, Zizzo G, Marrama P, Venneri MG, Della Casa L, Velardo A. 1994 α2-adrenergic activity is normal in patients with thyroid disease. Clin Endocrinol (Oxf). 40:235-239.
33. Liggett SB, Shah SD, Cryer PE. 1989 Increased fat and skeletal muscle β-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis. J Clin Invest. 83:803-809.